CompletedNCT03745820
This study exists to understand whether this type of care is both safe enough and useful enough to take further. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- Germany, Japan, Spain, United Kingdom, United States
- Sponsor
- Biogen
- Condition
- Schizophrenia
CompletedNCT05042050
This study exists to learn from real-world information that can show how a therapy or guided support program fits into care. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.
SchizophreniaOtherOver 16 Years
- Countries
- United Kingdom
- Sponsor
- University of Manchester
- Condition
- Schizophrenia
CompletedNCT02006628
This study exists to compare options and see whether the medication GWP42003 offers something meaningfully different. Researchers are trying to understand whether the medication GWP42003 can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Poland, Romania, United Kingdom
- Sponsor
- Jazz Pharmaceuticals
- Condition
- Schizophrenia
CompletedNCT03559426
This study exists to understand how symptom tracking and monitoring holds up over time after the earliest research stage. Researchers are trying to understand whether symptom tracking and monitoring can better prevent setbacks and support longer-term stability.
SchizophreniaOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- University College, London
- Condition
- Schizophrenia
CompletedNCT04310475
This study exists to explore whether cognitive behavioural therapy, a structured talking treatment, could improve care and understanding. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United Kingdom
- Sponsor
- King's College London
- Condition
- Schizophrenia
CompletedNCT03920384
This study exists to explore whether cognitive behavioural therapy, a structured talking treatment, could improve care and understanding. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherOver 16 Years
- Countries
- United Kingdom
- Sponsor
- University of Edinburgh
- Condition
- Schizophrenia
CompletedNCT06091163
This study exists to see whether a therapy or guided support program can make care clearer and more responsive. Researchers are trying to understand whether a therapy or guided support program can better support energy, concentration, and everyday functioning.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- United Kingdom
- Sponsor
- University of Oxford
- Condition
- Depression
Active Not RecruitingNCT06003582
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.
Mental healthOther
- Countries
- United Kingdom
- Sponsor
- University of Glasgow
- Condition
- Mental health
CompletedNCT04148508
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
Mental healthOtherFrom 16 Years to 22 Years
- Countries
- Belgium, Germany, Spain, United Kingdom
- Sponsor
- University of Exeter
- Condition
- Mental health
CompletedNCT05260060
This study exists to compare options and see whether cognitive behavioural therapy, a structured talking treatment, offers something meaningfully different. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
AnxietyOtherFrom 11 Years to 16 Years
- Countries
- United Kingdom
- Sponsor
- University of Manchester
- Condition
- Anxiety
CompletedNCT04792268
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits.
Mental healthOtherFrom 18 Years to 80 Years
- Countries
- United Kingdom
- Sponsor
- King's College London
- Condition
- Mental health
Active Not RecruitingNCT07541820
This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
ADHDOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- King's College London
- Condition
- ADHD
CompletedNCT04085172
This study exists to understand how the medication TAK-503 holds up over time after the earliest research stage. Researchers are trying to understand what the medication TAK-503 could change in day-to-day care and decision-making.
ADHDOtherFrom 6 Years to 17 Years
- Countries
- Austria, Belgium, Germany, Netherlands, Portugal, Spain, Sweden, United Kingdom, United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT04943796
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
ADHDOtherOver 18 Years
- Countries
- Canada, Germany, Spain, Sweden, Switzerland, United Kingdom
- Sponsor
- Takeda
- Condition
- ADHD
CompletedNCT01649232
This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 8 Years to 68 Years
- Countries
- United Kingdom
- Sponsor
- Spanish Foundation for Neurometrics Development
- Condition
- ADHD
CompletedNCT05518435
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
ADHDOtherOver 16 Years
- Countries
- United Kingdom
- Sponsor
- University of Exeter
- Condition
- ADHD
CompletedNCT01856686
This study exists to compare options and see whether a therapy or guided support program offers something meaningfully different. Researchers are trying to understand what a therapy or guided support program can reveal about signals in the brain or body that may guide care later on.
ADHDOtherFrom 7 Years to 13 Years
- Countries
- United Kingdom
- Sponsor
- Spanish Foundation for Neurometrics Development
- Condition
- ADHD
CompletedNCT05476549
This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 8 Years to 17 Years
- Countries
- United Kingdom
- Sponsor
- Northumbria University
- Condition
- ADHD
CompletedNCT05155696
This study exists to compare options and see whether questionnaires and follow-up reports offers something meaningfully different. Researchers are trying to understand whether questionnaires and follow-up reports can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 8 Years to 13 Years
- Countries
- United Kingdom
- Sponsor
- St. Mary's University, Twickenham
- Condition
- ADHD
CompletedNCT04832737
This study exists to see whether cognitive behavioural therapy, a structured talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 18 Years to 80 Years
- Countries
- United Kingdom
- Sponsor
- University of Huddersfield
- Condition
- ADHD
CompletedNCT05137704
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
ADHDOtherOver 18 Years
- Countries
- United Kingdom
- Sponsor
- Takeda
- Condition
- ADHD
CompletedNCT01244490
This study exists to compare options and see whether this type of care offers something meaningfully different. For people living with ADHD, that matters because care needs to work in daily life, not just in theory.
ADHDOtherFrom 6 Years to 17 Years
- Countries
- Austria, Canada, France, Germany, Ireland, Italy, Poland, Romania, Spain, Sweden, Ukraine, United Kingdom, United States
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT01500694
This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.
ADHDOtherFrom 6 Years to 17 Years
- Countries
- Austria, Belgium, France, Germany, Ireland, Italy, Netherlands, Poland, Romania, Spain, Sweden, Ukraine, United Kingdom
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT00763971
This study exists to explore whether the medication Lisdexamfetamine could improve care and understanding. For people living with ADHD, that matters because care needs to work in daily life, not just in theory.
ADHDOtherFrom 6 Years to 17 Years
- Countries
- Belgium, France, Germany, Hungary, Italy, Netherlands, Poland, Spain, Sweden, United Kingdom
- Sponsor
- Shire
- Condition
- ADHD
CompletedNCT01081145
This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
ADHDOtherFrom 6 Years to 17 Years
- Countries
- Belgium, Canada, France, Germany, Italy, Netherlands, Spain, Sweden, United Kingdom, United States
- Sponsor
- Shire
- Condition
- ADHD